GH deficiency in cancer survivors in the transition age: diagnosis and therapy.
Emilia SbardellaMarco CroccoTiziana FeolaFortuna PapaGiulia PulianiDaniele GianfrilliAndrea M IsidoriAshley B GrossmanPublished in: Pituitary (2021)
Endocrine dysfunction among CCSs has a high prevalence in the transition age and increase with time. Many endocrine disorders, including GHD, are often not diagnosed or under-diagnosed, probably due to the lack of specialized centers for the long-term follow-up. Therefore, it is crucial that transition specialized clinics should be increased in terms of number and specific skills in order to manage endocrine disorders in adolescence, a delicate and complex period of life. A multidisciplinary approach, also including psychological counseling, is essential in the follow-up and management of these patients in order to minimize their disabilities and maximize their quality of life.
Keyphrases
- end stage renal disease
- ejection fraction
- palliative care
- newly diagnosed
- primary care
- chronic kidney disease
- young adults
- peritoneal dialysis
- risk factors
- depressive symptoms
- oxidative stress
- stem cells
- patient reported outcomes
- physical activity
- smoking cessation
- bone marrow
- quality improvement
- replacement therapy
- antiretroviral therapy
- human immunodeficiency virus